Pulsed Dye Laser Treatment is Effective in the Treatment of Recalcitrant Viral Warts

Authors: SCHELLHAAS, ULRIKE1; GERBER, WOLFGANG1; HAMMES, STEFAN2; OCKENFELS, HANS M1

Source: Dermatologic Surgery, Volume 34, Number 1, January 2008 , pp. 67-72(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

BACKGROUND

Verrucae vulgaris can be removed in a variety of ways but a specific therapy of choice has not yet been developed. Doctors are faced with a challenge, especially in the treatment of recalcitrant warts. It has been suggested that the success of pulsed dye laser treatment lies in the fact that warts contain an increased number of dilated blood vessels. METHODS

Seventy-three patients (42 female, 31 male) with verrucae vulgaris on their hands or feet (1:1.5) were given a maximum of 12 treatments with a flashlamp-pumped pulsed dye laser every 2 weeks over a period of 24 weeks until complete clearance had been achieved. A laser energy density of 8 to 12 J/cm2 with a spot size of 5 mm and a pulse duration of 450 μsec were used. The minimum follow-up period was 6 months. RESULTS

A total of 15.1% patients achieved complete clearance after 1 session and 47.9% after 2 to 5 sessions, resulting in a remission of 63.0% patients after a maximum of 5 treatment sessions. A remission of 23.3% patients was seen after 6 to 9 treatments and a total of 89.0% of patients showed remission after a maximum of 10 sessions. Only three patients (4.1%) failed and five patients (6.9%) stopped the treatment on account of pain/noncompliance. Only one patient, from a group of patients treated between January 2003 and April 2004, has relapsed. CONCLUSION

Pulsed dye laser treatment is effective and safe in the treatment of recalcitrant viral warts.

The authors have indicated no significant interest with commercial supporters.

Document Type: Research article

DOI: 10.1111/j.1524-4725.2007.34010.x

Affiliations: 1: Department of Dermatology and Allergy, Klinikum Stadt Hanau, Hanau; 2: Laserklinik Karlsruhe, Karlsruhe, Germany

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A